The HHS on Thursday finalized a rule to incorporate the costs of kidney disease care into the method for calculating outer limits on how much Medicare patients must pay.
The rule (RIN: 0938-AT97) is designed to ensure that patients who want to enroll in private Medicare Advantage plans and who need extensive or expensive health care aren’t targeted or discriminated against.
The rule is the final piece of a broader set of Department of Health and Human Services regulations governing drug price comparisons under Medicare. Other portions of the rule were finalized in January 2021.
The portion of the proposed ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.